ARCHIVES

Emphasis On Early Disease In Clinical Trials, Early Lung Cancer Detection Seen As “Landmark”

This article is from The Cancer Letter archive.

Vol. 01 No. 38 | September 19, 1975

Download PDF Visit The Full Archive

Related Articles

NCI Study Tests Donor T Cells Against Breast Cancer

August 29, 2003

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

SAIC Frederick Offers Use Of Drug Facility

August 4, 1995

CTEP Drafts FDA Approval Guidelines

March 4, 1988

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012

No Benefit For Cetuximab In Early-Stage Colon Cancer

December 25, 2009